Diroximel fumarate-d4

SL-9404

Diroximel fumarate-d₄, >98%

Related CAS No. : [1577222-14-0] of the unlabelled compound

Synonyms : ALKS 8700-d₄; BIIB098-d₄

IUPAC Name : 2-(2,5-Dioxopyrrolidin-1-yl)ethyl-1,1,2,2-d₄ methyl fumarate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Diroximel fumarate, which is an orally active, well-tolerated monomethyl fumarate (MMF) proagent in controlled-release form. Diroximel fumarate is considered pharmacologically equivalent to its active metabolite, Dimethyl fumarate (DMF). With a favourable safety and efficacy profile, Diroximel fumarate shows potential for multiple sclerosis (MS) research. As a Nrf2 activator, it alleviates MGO-induced pain hypersensitivity.

References : Angela W. et al.: Neurology (P1.403), Apr 2018; Yousuf M. S. bioRxiv 12, 22, 572877, 2023.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.